SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001583771-23-000013
Filing Date
2023-11-20
Accepted
2023-11-20 15:59:44
Documents
71
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hepa-20230930.htm   iXBRL 10-Q 867420
2 EX-31.1 hepa-q3202310xqxexx311.htm EX-31.1 9828
3 EX-31.2 hepa-q3202310xqxexx312.htm EX-31.2 9681
4 EX-32.1 hepa-q3202310xqxexx321.htm EX-32.1 4675
5 EX-32.2 hepa-q3202310xqxexx322.htm EX-32.2 4659
11 hepa-20230930_g1.jpg GRAPHIC 10809
  Complete submission text file 0001583771-23-000013.txt   5143774

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hepa-20230930.xsd EX-101.SCH 36425
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hepa-20230930_cal.xml EX-101.CAL 47241
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hepa-20230930_def.xml EX-101.DEF 173036
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hepa-20230930_lab.xml EX-101.LAB 566727
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hepa-20230930_pre.xml EX-101.PRE 359422
65 EXTRACTED XBRL INSTANCE DOCUMENT hepa-20230930_htm.xml XML 586959
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 231422683
SIC: 2834 Pharmaceutical Preparations